Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.28	121.33	68.78	66.32	99.42
Short-Term Investments	73.84	26	-	19.75	-
Cash & Short-Term Investments	85.11	147.33	68.78	86.07	99.42
Cash Growth	-42.23%	114.21%	-20.09%	-13.43%	94.18%
Accounts Receivable	-	0.97	0.29	1.11	0.45
Other Receivables	22.01	24.4	22.44	18	9.39
Total Trade Receivables	22.01	25.37	22.73	19.11	9.84
Other Current Assets	11.54	14.66	11.63	11.79	7.46
Total Current Assets	118.66	187.37	103.14	116.97	116.72
Net Property, Plant & Equipment	1.75	1.98	2.31	2.66	2.63
Other Intangible Assets	0.29	0.31	0.36	0.39	0.03
Goodwill	10.62	9.39	9.98	9.69	10.26
Other Long-Term Assets	0.13	3.59	3.65	0.34	0.41
Total Assets	131.44	202.64	119.44	130.05	130.05
Accounts Payable	13.36	16.4	15.82	15.28	14.58
Current Portion of Leases	0.09	0.12	0.23	0.54	0.19
Unearned Revenue	0.17	0.31	6.57	10.72	5.74
Total Current Liabilities	13.61	16.82	22.62	26.55	20.51
Long-Term Leases	-	-	0.12	-	-
Other Long-Term Liabilities	55.45	51.79	74.99	76.8	98.02
Total Long-Term Liabilities	55.45	51.79	75.11	76.8	98.02
Total Liabilities	69.14	68.61	97.73	103.35	118.53
Common Stock	10.29	10.29	-7.56	6.52	6.07
Additional Paid-in Capital	617.56	609.56	-399.43	336.15	304.82
Accumulated Other Comprehensive Income	2.98	11.78	-2.48	2.52	2.08
Retained Earnings	562.57	474.04	387.77	-318.5	-301.45
Total Common Shareholders' Equity	1,193	1,106	-21.7	26.7	11.53
Shareholders' Equity	62.3	134.02	43.41	0	0
Total Liabilities & Equity	131.44	202.64	141.14	103.35	118.53
Total Debt	0.09	0.12	0.35	0.54	0.19
Net Cash (Debt)	85.03	147.22	68.44	85.53	99.24
Net Cash Growth	-42.24%	115.12%	-19.99%	-13.81%	95.60%
Net Cash Per Share	1.80	3.18	1.84	2.66	-
Book Value	1,193	1,106	-21.7	26.7	11.53
Book Value Per Share	25.27	23.91	-0.59	0.83	-
Tangible Book Value	1,182	1,096	-32.05	16.63	1.23
Tangible Book Value Per Share	25.04	23.70	-0.86	0.52	-

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q